BRIEF published on 05/20/2024 at 14:05, 4 months 8 days ago STMicroelectronics Announces Status of Common Share Repurchase Program Semiconductor Industry Market Abuse Regulation Treasury Shares Share Repurchase Program STMicroelectronics
PRESS RELEASE published on 05/20/2024 at 14:00, 4 months 8 days ago STMicroelectronics Announces Status of Common Share Repurchase Program STMicroelectronics announces details of common share repurchase program from May 13 to 17, 2024, including repurchase of 140,758 shares at EUR 38.3516 per share Regulated Market STMicroelectronics Common Share Repurchase Program Repurchase Transactions Semiconductor Technologies
BRIEF published on 05/13/2024 at 14:05, 4 months 15 days ago STMicroelectronics Details Recent Share Repurchase Activity Euronext Paris Share Repurchase Semiconductor Industry Market Abuse Regulation STMicroelectronics
PRESS RELEASE published on 05/13/2024 at 14:00, 4 months 15 days ago STMicroelectronics Announces Status of Common Share Repurchase Program STMicroelectronics discloses details of its common share repurchase program from May 06, 2024 to May 10, 2024, buying 175,000 shares on Euronext Paris. The purpose is to meet obligations from debt instruments Euronext Paris Market Abuse Regulation Share Repurchase Program STMicroelectronics Debt Financial Instruments
Published on 09/28/2024 at 02:06, 1 day 9 hours ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 1 day 9 hours ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day 11 hours ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 21 hours 22 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 12 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 13 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 16 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 16 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 17 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 17 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 17 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 17 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024